Holen Sie sich die Stockscreener-App
38.20
2.15%
-0.84
Schlusskurs vom Vortag:
$39.04
Offen:
$39.06
24-Stunden-Volumen:
1.05M
Relative Volume:
0.60
Marktkapitalisierung:
$3.32B
Einnahmen:
$19.32M
Nettoeinkommen (Verlust:
$-141.47M
KGV:
-22.67
EPS:
-1.6851
Netto-Cashflow:
$-120.48M
1W Leistung:
-11.25%
1M Leistung:
+0.29%
6M Leistung:
+51.59%
1J Leistung:
+136.68%
1-Tages-Spanne:
$38.04
$40.53
1-Wochen-Bereich:
$38.04
$43.69
52-Wochen-Spanne:
$11.26
$46.67
Liquidia Corp Stock (LQDA) Company Profile
Firmenname
Liquidia Corp
Sektor
Branche
Telefon
919.328.4400
Adresse
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Compare LQDA vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
38.20 | 3.40B | 19.32M | -141.47M | -120.48M | -1.6851 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-15 | Fortgesetzt | Jefferies | Buy |
| 2025-05-19 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-08-16 | Eingeleitet | Raymond James | Outperform |
| 2024-06-25 | Eingeleitet | Oppenheimer | Perform |
| 2024-01-05 | Bestätigt | Needham | Buy |
| 2022-09-19 | Fortgesetzt | Wedbush | Underperform |
| 2022-09-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2022-07-22 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-05-31 | Eingeleitet | BTIG Research | Buy |
| 2022-05-26 | Eingeleitet | BofA Securities | Buy |
| 2020-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-11-08 | Fortgesetzt | Jefferies | Buy |
| 2018-09-05 | Eingeleitet | Wedbush | Outperform |
| 2018-08-20 | Eingeleitet | Jefferies | Buy |
| 2018-08-20 | Eingeleitet | Needham | Buy |
Alle ansehen
Liquidia Corp Aktie (LQDA) Neueste Nachrichten
Is Liquidia Corporation stock influenced by commodity pricesJuly 2025 Price Swings & Weekly Stock Breakout Alerts - mfd.ru
While Liquidia (NASDAQ:LQDA) shareholders have made 991% in 5 years, increasing losses might now be front of mind as stock sheds 9.3% this week - Yahoo Finance
EXEL or LQDA: Which Is the Better Value Stock Right Now? - Bitget
Caprock Group LLC Purchases New Shares in Liquidia Corporation $LQDA - MarketBeat
Liquidia Technologies stock hits 52-week high at 43.0 USD - Investing.com
Surging Revenue And Technical Momentum Could Be A Game Changer For Liquidia (LQDA) - simplywall.st
LQDA SEC FilingsLiquidia Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
Liquidia Corp (NASDAQ:LQDA) Identified as High-Growth Momentum Candidate by Minervini Trend Template - ChartMill
Liquidia (NASDAQ:LQDA) Sets New 52-Week HighHere's Why - MarketBeat
Liquidia Reaches Analyst Target Price - Nasdaq
Liquidia Technologies stock hits all-time high at 43.44 USD - Investing.com
LQDA March 13th Options Begin Trading - Nasdaq
Liquidia (NASDAQ:LQDA) CAO Dana Boyle Sells 1,580 Shares - MarketBeat
Liquidia to Present Clinical Data Across Its Portfolio at the Pulmonary Vascular Research Institute 2026 Annual Congress - The Manila Times
Liquidia Options Trading: A Deep Dive into Market Sentiment - Benzinga
Inflation Data: What drives Liquidia Corporations stock price2025 Bull vs Bear & Safe Entry Momentum Tips - baoquankhu1.vn
Liquidia (NASDAQ:LQDA) Reaches New 52-Week HighTime to Buy? - MarketBeat
Liquidia Technologies stock hits all-time high at 41.77 USD - Investing.com
Liquidia Corporation (NASDAQ:LQDA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Institution Moves: Does Liquidia Corporation outperform in volatile marketsBear Alert & Stepwise Trade Execution Plans - baoquankhu1.vn
Liquidia Corp and MP Materials See Surge in Options Trading Volume - Intellectia AI
Liquidia Corporation (NASDAQ:LQDA) Short Interest Update - MarketBeat
Liquidia (NASDAQ:LQDA) Rating Lowered to Hold at Wall Street Zen - MarketBeat
Campbell & CO Investment Adviser LLC Takes Position in Liquidia Corporation $LQDA - MarketBeat
Published on: 2026-01-17 14:39:47 - baoquankhu1.vn
Liquidia Target of Unusually Large Options Trading (NASDAQ:LQDA) - MarketBeat
Liquidia’s YUTREPIA Launch Turned A Small Biotech Into A Sales Story - Finimize
Laughing Water Capital’s Updates on Liquidia Corp (LQDA) - Insider Monkey
Liquidia (NASDAQ:LQDA) Reaches New 1-Year HighHere's What Happened - MarketBeat
Liquidia Corporation (LQDA) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Liquidia (NASDAQ:LQDA) Upgraded by Zacks Research to Strong-Buy Rating - MarketBeat
Liquidia corp general counsel sells $1m in shares By Investing.com - Investing.com UK
Risk On: Is Liquidia Corporation stock ready for breakout2025 Price Targets & High Win Rate Trade Alerts - moha.gov.vn
Liquidia’s chief business officer Adair sells $507k in LQDA stock - Investing.com Nigeria
Liquidia’s chief business officer Adair sells $507k in LQDA stock By Investing.com - Investing.com South Africa
Liquidia corp general counsel sells $1m in shares - Investing.com
Liquidia (NASDAQ:LQDA) CFO Sells $1,382,364.76 in Stock - MarketBeat
Liquidia (NASDAQ:LQDA) Insider Sells $492,765.95 in Stock - MarketBeat
Liquidia (NASDAQ:LQDA) Insider Sells $791,345.06 in Stock - MarketBeat
Scott Moomaw Sells 20,533 Shares of Liquidia (NASDAQ:LQDA) Stock - MarketBeat
Insider Selling: Liquidia (NASDAQ:LQDA) Insider Sells 13,548 Shares of Stock - MarketBeat
Liquidia (NASDAQ:LQDA) CAO Sells $413,489.21 in Stock - MarketBeat
Liquidia Insider Sold Shares Worth $413,489, According to a Recent SEC Filing - marketscreener.com
Jefferies Raises Price Target for Liquidia (LQDA) to $55.00 with Buy Rating | LQDA Stock News - GuruFocus
Jefferies raises Liquidia stock price target to $55 on strong Yutrepia sales - Investing.com
Analyst Expectations For Liquidia's Future - Benzinga
BTIG reiterates Buy rating on Liquidia stock, maintains $49 price target - Investing.com
BTIG Reiterates Buy Rating for LQDA with $49 Target Price | LQDA Stock News - GuruFocus
Finanzdaten der Liquidia Corp-Aktie (LQDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Liquidia Corp-Aktie (LQDA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Adair Jason | Chief Business Officer |
Jan 26 '26 |
Sale |
41.65 |
688 |
28,655 |
211,169 |
| Krepp Sarah | Chief Human Resource Officer |
Jan 12 '26 |
Sale |
37.43 |
13,165 |
492,766 |
140,769 |
| Moomaw Scott | Chief Commercial Officer |
Jan 12 '26 |
Sale |
37.43 |
20,533 |
768,550 |
154,514 |
| Kaseta Michael | CFO and COO |
Jan 12 '26 |
Sale |
37.43 |
36,932 |
1,382,365 |
350,919 |
| Adair Jason | Chief Business Officer |
Jan 12 '26 |
Sale |
37.43 |
13,548 |
507,102 |
184,174 |
| Schundler Russell | General Counsel |
Jan 12 '26 |
Sale |
37.43 |
27,289 |
1,021,427 |
579,394 |
| JEFFS ROGER | Chief Executive Officer |
Jan 12 '26 |
Sale |
37.43 |
66,610 |
2,493,212 |
1,037,528 |
| Boyle Dana | Chief Accounting Officer |
Jan 12 '26 |
Sale |
37.43 |
11,047 |
413,489 |
156,700 |
| Saggar Rajeev | Chief Medical Officer |
Jan 12 '26 |
Sale |
37.43 |
21,142 |
791,345 |
176,883 |
| Schundler Russell | General Counsel |
Dec 01 '25 |
Sale |
32.19 |
1,072 |
34,508 |
577,288 |
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):